CX Institutional’s First Trust Financials AlphaDEX Fund FXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Sell
8,438
-7,258
-46% -$432K 0.02% 464
2026
Q1
$882K Buy
15,696
+10,148
+183% +$602K 0.03% 359
2025
Q4
$335K Sell
5,548
-7,591
-58% -$446K 0.01% 537
2025
Q3
$780K Buy
13,139
+8,554
+187% +$497K 0.02% 339
2025
Q2
$257K Sell
4,585
-14,678
-76% -$769K 0.01% 547
2025
Q1
$1.02M Buy
+19,263
New +$1.05M 0.04% 263
2023
Q4
Sell
-5,868
Closed -$222K 545
2023
Q3
$222K Buy
+5,868
New +$232K 0.01% 459
2023
Q1
Sell
-35,821
Closed -$1.47M 514
2022
Q4
$1.47M Buy
35,821
+17,684
+98% +$727K 0.09% 223
2022
Q3
$668K Sell
18,137
-27,183
-60% -$1.11M 0.05% 311
2022
Q2
$1.76M Buy
+45,320
New +$1.91M 0.13% 186
2018
Q4
Sell
-2,967
Closed -$95K 541
2018
Q3
$95K Buy
+2,967
New +$95.9K 0.03% 150

Other funds holding FXO

CX Institutional's FXO Position: Q2 2026 in Review

CX Institutional reduced its First Trust Financials AlphaDEX Fund (FXO) stake by 46% in Q2 2026, selling an estimated $432K and leaving 8,438 shares worth $527K. The position accounts for 0.02% of the portfolio, ranked #464.

CX Institutional first reported a position in FXO in Q3 2018 and has held it in 11 quarters since. The position peaked at $1.76M in Q2 2022. 220 funds tracked by Wall St. Rank hold FXO as of Q2 2026.

  • CX Institutional held 8,438 shares of First Trust Financials AlphaDEX Fund worth $527K as of Q2 2026.
  • CX Institutional sold 7,258 First Trust Financials AlphaDEX Fund shares in Q2 2026, an estimated $432K.
  • First Trust Financials AlphaDEX Fund made up 0.02% of CX Institutional's portfolio in Q2 2026, its #464 holding.
  • CX Institutional first reported a position in First Trust Financials AlphaDEX Fund in Q3 2018 and has held it in 11 quarters since.
  • CX Institutional's First Trust Financials AlphaDEX Fund position peaked at $1.76M in Q2 2022.
  • 220 funds tracked by Wall St. Rank held First Trust Financials AlphaDEX Fund as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.